Stamford, CT -- (SBWIRE) -- 12/05/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: IBC ADVANCED ALLOYS(OTCMKTS:IAALF), TITAN MEDICAL INC(OTCMKTS:TITXF), AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), Adamis Pharmaceuticals Corp(OTCMKTS:ADMP)
IBC ADVANCED ALLOYS(OTCMKTS:IAALF) increased 15.63% at the price of $0.185 recently on a traded volume of 311,891.00 shares, in comparison to 91,230.00 shares of average trading volume. So far this year, the stock is down over -43.6%.
The company has a total market capitalization of $9.05 million. BC Advanced Alloys Corp. develops, manufactures, and sells specialty copper alloys and beryllium aluminum castings in North America, Europe, and Asia. The company offers various copper alloys as castings and forgings, including beryllium copper, chrome copper, and aluminum bronze in plate, block, bar, and rings, as well as specialty copper alloy forgings for plastic mold tooling and resistance welding applications.
For How Long IAALF will Fight for Profitability? Read This Trend Analysis report
TITAN MEDICAL INC(OTCMKTS:TITXF) plunged -1.88% at the trading price of $1.08 on a traded volume of 102,100.00 shares till now, whereas its average trading volume is 260,077.00 shares. In the last three months, the stock is up 112.18%. The Intra-day range for the stock is $1.05 and $1.09. Titan Medical Inc., a development stage company, engages in the design and development of Amadeus robotic surgical system for application in minimally invasive surgery (MIS). The Amadeus surgical system is under development and comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures
Has TITXF Found The Bottom And Ready To Gain Momentum? Find Out Here
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) jumped up 5.45% at the $0.058 recently. The 52-week range for the stock is $0.027 and $0.20. Its introductory price for the day was $0.056, with the overall traded volume of 2.03million shares. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Will AMBS Continue To Move Higher? Find Out Here
Adamis Pharmaceuticals Corp(OTCMKTS:ADMP), after opening its shares at the price of $0.50, jumped up 18.02% , its recent trading price was $0.590 for the day. The stock moved on a traded volume of 354,697.00 shares, in comparison to 175,373.00 shares of average trading volume. The 52-week range for the stock is $0.20 and $1.01. Its introductory price for the day was $0.50. Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc.operates through its wholly owned subsidiaries Cellegy Holdings, Inc., Adamis Corporation and Biosyn, Inc. Adamis Corporation has two wholly owned subsidiaries: Adamis Viral Therapies, Inc. (Adamis Viral) and Adamis Laboratories, Inc. (Adamis Labs). Adamis Labs is a specialty pharmaceutical company.
Why Should Investors Buy ADMP After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)